• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[苦参碱对大鼠输精管的作用与钙通道激活的关系]

[Relation of effects of matrine on rat vasa deferens to activation of calcium channels].

作者信息

Wang G L, Zhang S S, Li Z H, Liu S F

机构信息

Department of Pharmacology, Inner Mongolia Medical College, Huhehaote, China.

出版信息

Zhongguo Yao Li Xue Bao. 1994 May;15(3):279-81.

PMID:7976388
Abstract

Effective mechanisms of matrine (Mat) in contraction were observed in isolated rat vasa deferens. Mat caused a strong concentration-dependent contraction of vasa deferens, and this contraction was competitively inhibited by prazosin (Pra, 10 mumol.L-1) and nifedipine (Nif, 50 nmol.L-1), with depression of maximal responses. Their pA2 value was 5.1 and 9.29, respectively. The contraction was also inhibited by verapamil (Ver, 1 mumol.L-1) with depression of maximal responses; but this antagonism was noncompetitive. Its pD2 value was 6.07. Mat promoted CaCl2-induced contraction of vas deferens. The effect of Mat was enhanced in proportion to increase in concentrations of CaCl2. Mat markedly strengthened KCl-induced contraction of vas deferens. The results suggest that one of the mechanisms of the contractive effects of Mat within a certain range of concentrations was related to the activation of the calcium channel.

摘要

在离体大鼠输精管中观察了苦参碱(Mat)的收缩作用机制。Mat引起输精管强烈的浓度依赖性收缩,这种收缩被哌唑嗪(Pra,10 μmol·L⁻¹)和硝苯地平(Nif,50 nmol·L⁻¹)竞争性抑制,最大反应降低。它们的pA2值分别为5.1和9.29。维拉帕米(Ver,1 μmol·L⁻¹)也抑制收缩,最大反应降低;但这种拮抗作用是非竞争性的。其pD2值为6.07。Mat促进氯化钙诱导的输精管收缩。Mat的作用随氯化钙浓度增加而增强。Mat显著增强氯化钾诱导的输精管收缩。结果表明,在一定浓度范围内,Mat收缩作用的机制之一与钙通道的激活有关。

相似文献

1
[Relation of effects of matrine on rat vasa deferens to activation of calcium channels].[苦参碱对大鼠输精管的作用与钙通道激活的关系]
Zhongguo Yao Li Xue Bao. 1994 May;15(3):279-81.
2
[Relationship between the positive inotropic action of matrine and extracellular calcium].苦参碱正性肌力作用与细胞外钙的关系
Yao Xue Xue Bao. 1990;25(8):637-9.
3
Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.大鼠输精管中α1-肾上腺素能受体亚型的鉴定:结合与功能研究。
Br J Pharmacol. 1992 Nov;107(3):697-704. doi: 10.1111/j.1476-5381.1992.tb14509.x.
4
Functional identification of alpha 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen.人前列腺中α1 -肾上腺素能受体亚型的功能鉴定:与大鼠输精管和脾脏中的受体亚型比较。
Eur J Pharmacol. 1994 Nov 14;265(1-2):61-6. doi: 10.1016/0014-2999(94)90223-2.
5
Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.介导大鼠主动脉、输精管和脾脏收缩的α1-肾上腺素能受体亚型的研究。
Br J Pharmacol. 1993 May;109(1):80-7. doi: 10.1111/j.1476-5381.1993.tb13534.x.
6
A comparison of the effects of nifedipine and verapamil on rat vas deferens.硝苯地平与维拉帕米对大鼠输精管作用的比较。
Br J Pharmacol. 1981 Jun;73(2):321-3. doi: 10.1111/j.1476-5381.1981.tb10424.x.
7
Effects of methoxamine and barium on 45Ca2+ fluxes in the rat vas deferens.甲氧明和钡对大鼠输精管中45Ca2+通量的影响。
Eur J Pharmacol. 1992 Apr 10;225(4):313-20. doi: 10.1016/0922-4106(92)90105-5.
8
Investigation of the effects of α1-adrenoceptor antagonism and L-type calcium channel blockade on ejaculation and vas deferens and seminal vesicle contractility in vitro.研究 α1-肾上腺素能受体拮抗和 L 型钙通道阻断对体外射精和输精管及精囊收缩的影响。
J Sex Med. 2012 Jan;9(1):159-68. doi: 10.1111/j.1743-6109.2011.02410.x. Epub 2011 Aug 2.
9
Differential effects of drugs interacting with autonomic transmitters on responses of rat vas deferens to field stimulation.与自主神经递质相互作用的药物对大鼠输精管场刺激反应的不同影响。
J Auton Pharmacol. 2000 Apr;20(2):87-97. doi: 10.1046/j.1365-2680.2000.00176.x.
10
Effects of calcium-entry modulators on the biphasic neurogenic contractions in the circular muscle of guinea pig vas deferens.钙内流调节剂对豚鼠输精管环形肌双相神经源性收缩的影响。
Jpn J Pharmacol. 1989 Jan;49(1):59-65. doi: 10.1254/jjp.49.59.